Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA

Nature

Volumn 474, Issue 7351, 2011, Pages 390-397

  Wang, Dong ^a   Garcia Bassets, Ivan ^b   Benner, Chris ^a   Li, Wenbo ^a   Su, Xue ^b,c   Zhou, Yiming ^d   Qiu, Jinsong ^a   Liu, Wen ^b,c   Kaikkonen, Minna U ^a   Ohgi, Kenneth A ^b   Glass, Christopher K ^a   Rosenfeld, Michael G ^b   Fu, Xiang Dong ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Digomics LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ENHANCER TEMPLATED NON CODING RNA; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

CELL ORGANELLE; COHORT ANALYSIS; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENOME; HORMONE; MAMMAL; NUMERICAL MODEL; PHYSIOLOGICAL RESPONSE; RNA; TUMOR;

ARTICLE; CELL DIFFERENTIATION; DISEASE COURSE; DOWN REGULATION; GENE ACTIVATION; GENE EXPRESSION; HORMONE RESPONSE; HUMAN; HUMAN CELL; NUCLEAR REPROGRAMMING; NUCLEOSOME; PRIORITY JOURNAL; PROSTATE TUMOR; RECEPTOR BINDING; TRANSCRIPTION INITIATION;

BASE SEQUENCE; CELL LINE, TUMOR; CELL LINEAGE; DIHYDROTESTOSTERONE; DOWN-REGULATION; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENOME, HUMAN; HEK293 CELLS; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; HISTONES; HUMANS; KALLIKREINS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RNA, SMALL INTERFERING; RNA, UNTRANSLATED; TRANSCRIPTION, GENETIC;

MAMMALIA;

EID: 79959198166     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature10006     Document Type: Article

References (40)

1. Heintzman, N. D. et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459, 108-112 (2009).
2. Heintzman, N. D. et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the humangenome. Nature Genet.39, 311-318 (2007). (Pubitemid 46328487)
3. Pennacchio, L. A. et al. In vivo enhancer analysis of human conserved non-coding sequences. Nature 444, 499-502 (2006). (Pubitemid 44809068)
4. Visel, A. et al. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457, 854-858 (2009).
5. Kim, T. K. et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 465, 182-187 (2010).
6. Core, L. J., Waterfall, J. J. & Lis, J. T. Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science 322, 1845-1848 (2008).
7. Lee, T. I. & Young, R. A. Transcription of eukaryotic protein-coding genes. Annu. Rev. Genet. 34, 77-137 (2000). (Pubitemid 32065917)
8. Rosenfeld, M. G., Lunyak, V. V. & Glass, C. K. Sensors and signals: a coactivator/ corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 20, 1405-1428 (2006). (Pubitemid 43830648)
9. Lupien, M. et al. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132, 958-970 (2008). (Pubitemid 351391952)
10. Gao, N. et al. Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation. Development 132, 3431-3443 (2005). (Pubitemid 41246118)
11. Mirosevich, J.,Gao, N. & Matusik, R. J. Expressionof Foxa transcriptionfactors in the developing and adult murine prostate. Prostate 62, 339-352 (2005). (Pubitemid 40224139)
12. Kang, Z., Janne, O. A. & Palvimo, J. J. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. Mol. Endocrinol. 18, 2633-2648 (2004). (Pubitemid 39482054)
13. Shim, E. Y.,Woodcock, C. & Zaret, K. S.Nucleosome positioning by the winged helix transcription factor HNF3. Genes Dev. 12, 5-10 (1998). (Pubitemid 28083653)
14. Holmqvist, P. H., Belikov, S., Zaret, K. S. & Wrange, O. FoxA1 binding to the MMTV LTR modulates chromatin structure and transcription. Exp. Cell Res. 304, 593-603 (2005). (Pubitemid 40321135)
15. Crowe, A. J. et al. Hepatocyte nuclear factor 3 relieves chromatin-mediated repression of the a-fetoprotein gene. J. Biol. Chem. 274, 25113-25120 (1999).
16. Cirillo, L. A. et al. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol. Cell 9, 279-289 (2002). (Pubitemid 34195554)
17. Wang, Q. et al. Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell 138, 245-256 (2009).
18. Hurtado, A., Holmes, K. A., Ross-Innes, C. S., Schmidt, D. & Carroll, J. S. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nature Genet. 43, 27-33 (2011).
19. Thomsen, M. K. et al. SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation. Cancer Res. 70, 979-987 (2010).
20. Wang, H. et al.SOX9is expressedinhumanfetal prostate epitheliumand enhances prostate cancer invasion. Cancer Res. 68, 1625-1630 (2008). (Pubitemid 351416545)
21. Ogawa, S. et al. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122, 707-721 (2005). (Pubitemid 41242636)
22. Lee, H. J., Hwang, M., Chattopadhyay, S., Choi, H. S. & Lee, K. Hepatocyte nuclear factor-3a (HNF-3a) negatively regulates androgen receptor transactivation in prostate cancer cells. Biochem. Biophys. Res. Commun. 367, 481-486 (2008).
23. Gao, N. et al. The role of hepatocyte nuclear factor-3a (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes. Mol. Endocrinol. 17, 1484-1507 (2003). (Pubitemid 36930465)
24. Kagey, M. H. et al. Mediator and cohesin connect gene expression and chromatin architecture. Nature 467, 430-435 (2010).
25. He, H. H. et al. Nucleosome dynamics define transcriptional enhancers. Nature Genet. 42, 343-347 (2010).
26. Laitinen, S., Karhu, R., Sawyers, C. L., Vessella, R. L. & Visakorpi, T. Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization. Genes Chromosom. Cancer 35, 66-73 (2002). (Pubitemid 34847870)
27. Legrier, M. E. et al. Hormone escape is associated with genomic instability in a human prostate cancer model. Int. J. Cancer 124, 1103-1111 (2009).
28. Wolf, M. et al. High-resolution analysis of gene copy number alterations in human prostate cancer using CGHon cDNAmicroarrays: impact of copy number on gene expression. Neoplasia 6, 240-247 (2004). (Pubitemid 38657080)
29. Garcia-Bassets, I. et al. Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 128, 505-518 (2007). (Pubitemid 46198894)
30. Ingolia, N. T., Ghaemmaghami, S., Newman, J. R. & Weissman, J. S. Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science 324, 218-223 (2009).
31. Hu, Q. et al. Enhancing nuclear receptor-induced transcription requires nuclear motor and LSD1-dependent gene networking in interchromatin granules. Proc. Natl Acad. Sci. USA 105, 19199-19204 (2008).
32. Holbro, T. et al. The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to derive breast tumor cell proliferation. Proc. Natl Acad. Sci. USA 100, 8933-8938 (2003). (Pubitemid 36899201)
33. Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576-589 (2010).
34. Barski, A. et al. High-resolution profiling of histone methylations in the human genome. Cell 129, 823-837 (2007). (Pubitemid 46802390)
35. Linhart, C., Halperin, Y. & Shamir, R. Transcription factor and microRNA motif discovery: the Amadeus platform and a compendium of metazoan target sets. Genome Res. 18, 1180-1189 (2008). (Pubitemid 351931169)
36. Chandran, U. R. et al. Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer 7, 64 (2007).
37. Yu, Y. P. et al. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J. Clin. Oncol. 22, 2790-2799 (2004). (Pubitemid 41079896)
38. Varambally, S. et al. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 8, 393-406 (2005). (Pubitemid 41579834)
39. Glinsky, G. V., Glinskii, A. B., Stephenson, A. J., Hoffman, R. M. & Gerald, W. L. Gene expression profiling predicts clinical outcome of prostate cancer. J. Clin. Invest. 113, 913-923 (2004). (Pubitemid 38544150)
40. Taylor, B. S. et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11-22 (2010).